Exploring knowledge and perceptions on generic drugs of final year pharmacy school students in Greece

References

• Carone G, Schwierz C, Xavier A. Cost-containment policies in public pharmaceutical spending in the EU. Brussels, Belgium: European Commission, Directorate-General for Economic and Financial Affairs Publications; 2012.
   Google Scholar
• European Medicines Agency (EMA). Questions and answers on generic medicines. Canary Wharf: EMA; 2011 [cited 2017 Jun 21]. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Medicine_QA/2009/11/WC500012382.pdf
   Google Scholar
• Sheppard A. Generic medicines: essential contributors to the long-term health of society. Danbury (CT) : IMS Health; 2009.
   Google Scholar
• Woerkom M, Piepenbrink H, Godman B, et al. Ongoing measures to enhance the efficiency of prescribing of proton pump inhibitors and statins in the Netherlands: influence and future implications. J Comp Eff Res. 2012 Nov;1(6):527–538. .
   PubMed Web of Science ®Google Scholar
• Bennie M, Godman B, Bishop I, et al. Multiple initiatives continue to enhance the prescribing efficiency for the proton pump inhibitors and statins in Scotland. Expert Rev Pharmacoecon Outcomes Res. 2012;12(1):125–130.
   PubMed Web of Science ®Google Scholar
• Cameron A, Mantel-Teeuwisse AK, Leufkens HGM, et al. Switching from originator brand medicines to generic equivalents in selected developing countries: how much Could be saved? Value Health. 2012;15(5):664–673.
   PubMed Web of Science ®Google Scholar
• Godman B, Shrank W, Andersen M, et al. Comparing policies to enhance prescribing efficiency in Europe through increasing generic utilization: changes seen and global implications. Expert Rev Pharmacoecon Outcomes Res. 2010;10(6):707–722.
   PubMed Web of Science ®Google Scholar
• Dylst P, Vulto A, Simoens S. Demand-side policies to encourage the use of generic medicines: an overview. Expert Rev Pharmacoecon Outcomes Res. 2013;13(1):59–72.
   PubMed Web of Science ®Google Scholar
• Dylst P, Vulto A, Simoens S. Societal value of generic medicines beyond cost-saving through reduced prices. Expert Rev Pharmacoecon Outcomes Res. 2015;15(4):701–711.
   PubMed Web of Science ®Google Scholar
• Godman B, Wettermark B, van Woerkom M, et al. Multiple policies to enhance prescribing efficiency for established medicines in Europe with a particular focus on demand-side measures: findings and future implications. Front Pharmacol. 2014;5:106.
   PubMed Web of Science ®Google Scholar
• OECD. Health at a Glance 2011: OECD indicators. OECD Publications, Paris; 2011.
   Google Scholar
• Vogler S, Zimmermann N, Leopold C, et al. Pharmaceutical policies in European countries in response to the global financial crisis. South Med Rev. 2011;4(2):69–79.
   PubMedGoogle Scholar
• Kanavos P. Measuring performance in off-patent drug markets: A methodological framework and empirical evidence from twelve EU member states. Health Policy. 2014;118:229–241.
   PubMed Web of Science ®Google Scholar
• Ifanti AA, Argyriou AA, Kalofonou FH, et al. Financial crisis and austerity measures in Greece: their impact on health promotion policies and public health care. Health Policy. 2013;113(1–2):8–12.
   PubMed Web of Science ®Google Scholar
• PEF (Panhellenic Association of Pharmaceutical Industry). We want incentives for Greek generics 9/5/2015; [cited 2017 Jun 21]. Available from: http://www.pef.gr//?x=19&y=19&s=%CE%B3%CE%B5%CE%BD%CF%8C%CF%83%CE%B7%CE%BC%CE%B1 (in Greek).
   Google Scholar
• Kesselheim AS, Misono AS, Lee JL, et al. Clinical equivalence of generic and brand-name drugs used in cardiovascular disease. JAMA. 2008;300(21):2514.
   PubMed Web of Science ®Google Scholar
• Gagne JJ, Choudhry NK, Kesselheim AS, et al. Comparative effectiveness of generic and brand-name statins on patient outcomes. Ann Intern Med. 2014;161(6):400.
   PubMed Web of Science ®Google Scholar
• Corrao G, Soranna D, Arfè A, et al. Are generic and brand-name statins clinically equivalent? Evidence from a real data-base. Eur J Intern Med. 2014;25(8):745–750.
   PubMed Web of Science ®Google Scholar
• Corrao G, Soranna D, La Vecchia C, et al. Medication persistence and the use of generic and brand-name blood pressure-lowering agents. J Hypertens. 2014;32(5):1146–1153.
   PubMed Web of Science ®Google Scholar
• Corrao G, Soranna D, Merlino L, et al. Similarity between generic and brand-name antihypertensive drugs for primary prevention of cardiovascular disease: evidence from a large population-based study. Eur J Clin Invest. 2014;44(10):933–939.
   PubMed Web of Science ®Google Scholar
• Paton C. Generic clozapine: outcomes after switching formulations. Br J Psychiatry. 2006;189(02):184–185.
   PubMedGoogle Scholar
• Veronin MA. Should we have concerns with generic versus brand antimicrobial drugs? A review of issues. J Pharm Health Serv Res. 2011;2(3):135–150.
   Google Scholar
• Gagne JJ, Kesselheim AS, Choudhry NK, et al. Comparative effectiveness of generic versus brand-name antiepileptic medications. Epilepsy Behav. 2015;52:14–18.
   PubMed Web of Science ®Google Scholar
• Kesselheim AS, Stedman MR, Bubrick EJ, et al. Seizure outcomes following the use of generic versus brand-name antiepileptic drugs: a systematic review and meta-analysis. Drugs. 2010;70(5):605–621.
   PubMed Web of Science ®Google Scholar
• Yamada M, Welty TE. Generic substitution of antiepileptic drugs: a systematic review of prospective and retrospective studies. Ann Pharmacother. 2011;45(11):1406–1415.
   PubMed Web of Science ®Google Scholar
• Labiris G, Fanariotis M, Kastanioti C, et al. Greek physicians’ perceptions on generic drugs in the era of austerity. Scientifica (Cairo). 2015;2015:251792..
   PubMed Web of Science ®Google Scholar
• Toverud EL, Hartmann K, Håkonsen HA. Systematic review of physicians’ and pharmacists’ perspectives on generic drug use: what are the global challenges? Appl Health Econ Health Policy. 2015;13:35–45.
   Web of Science ®Google Scholar
• Tobin MR, Laing R. Generic medicine: boston University students’ perceptions and surprising lack of knowledge. J Generic Med. 2015;11(3–4):136–145.
   Google Scholar
• Skaltsas LN, Vasileiou KZ. Patients’ perceptions of generic drugs in Greece. Health Policy. 2015;119:1406–1414.
   PubMed Web of Science ®Google Scholar
• Quintal C, Mendes P. Underuse of generic medicines in Portugal: an empirical study on the perceptions and attitudes of patients and pharmacists. Health Policy. 2012;104:61–68.
   PubMed Web of Science ®Google Scholar
• Hassali MA, Shafie AA, Jamshed S, et al. Consumers’ views on generic medicines: A review of the literature. Int J Pharm Pract. 2009;17(2):79–88.
   PubMedGoogle Scholar
• Pichetti S, Sermet C, Godman B, et al. Multilevel analysis of the influence of patients’ and general practitioners’ characteristics on patented versus multiple-sourced statin prescribing in France. Appl Health Econ Health Policy. 2013;11(3):205–218.
   PubMedGoogle Scholar
• Frouzi E, Chatzea VE, Sifaki Pistolla D, et al. Knowledge and attitudes of Greek Physicians towards generic prescribing after the economic crisis. Ijpsr. 2013;4(10):125–133.
   Google Scholar
• Tsiantou V, Zavras D, Kousoukalou H, et al. Generic medicines: greek physicians’ perceptions and prescribing practices. J Clin Pharm Ther. 2009;34:547–554.
   PubMed Web of Science ®Google Scholar
• Baumgärtel C, Godman B, Malmstrom RE, et al. What lessons can be learned from the launch of generic clopidogrel? GaBI J. 2012;1(2):58–68.
   Google Scholar
• Editorial. Generic bashing: effective but illegal. Rev Prescrire. 2013;33(360):779.
   Google Scholar
• Godman B, Wettermark B, Hoffmann M, et al. Multifaceted national and regional drug reforms and initiatives in ambulatory care in Sweden: global relevance. Expert Rev Pharmacoecon Outcomes Res. 2009;9(1):65–83.
   PubMedGoogle Scholar
• Olsson E, Wallach-Kildemoes H, Ahmed B, et al. The influence of generic substitution on the content of patient-pharmacist communication in Swedish community pharmacies. Int J Pharm Pract. 2017;25(4):274–281.
   PubMed Web of Science ®Google Scholar
• Gafà M, Bilbija S, Martinova A, et al. Pharmacoeconomics: A view of EPSA member countries on issues related to awareness of the topic and the undergraduate curriculum. Pharm Educ. 2002;2(4):171–175.
   Google Scholar